Home
About
Overview
Sharing Data
ORCID
Help
History (2)
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Visible-Light-Activated Bactericidal Functions of Carbon "Quantum" Dots.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2011 Jun; 82(6):671-3.
View in:
PubMed
subject areas
Adolescent
Adult
Antibodies, Monoclonal, Murine-Derived
Child
Child, Preschool
Female
Humans
Immunologic Factors
Lambert-Eaton Myasthenic Syndrome
Male
Middle Aged
Myasthenia Gravis
Protein-Tyrosine Kinases
Receptor Protein-Tyrosine Kinases
Receptors, Cholinergic
Retrospective Studies
Rituximab
authors with profiles
Michael R Rose